Current Cancer Drug Targets
Title: Author Index To Volume 2
Volume: 3 Issue: 1
Export Options
About this article
Cite this article as:
Author Index To Volume 2, Current Cancer Drug Targets 2003; 3 (1) . https://dx.doi.org/10.2174/1568009033333600
DOI https://dx.doi.org/10.2174/1568009033333600 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Carcinoembryonic Antigen as a Target to Induce Anti-Tumor Immune Responses
Current Cancer Drug Targets Substitution at Phenyl Rings of Chalcone and Schiff Base Moieties Accounts for their Antiproliferative Activity
Anti-Cancer Agents in Medicinal Chemistry Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member:
Current Drug Targets Biological Function and Medicinal Research Significance of G-Quadruplex Interactive Proteins
Current Topics in Medicinal Chemistry Isolation of Bioactive Natural Products from Myxomycetes
Medicinal Chemistry Contemporary Pediatric Palliative Care: Myths and Barriers to Integration into Clinical Care
Current Pediatric Reviews Mevalonate Pathway and Human Cancers
Current Molecular Pharmacology New Drugs from Old Natural Compounds: Scarcely Investigated Sesquiterpenes as New Possible Therapeutic Agents
Current Medicinal Chemistry Meet Our Editorial Board Member
Pharmaceutical Nanotechnology Role of Radiopharmaceuticals in Development of Inhaled Drugs
Current Pharmaceutical Design The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design Curcumin and Genistein: the Combined Effects on Disease-associated CFTR Mutants and their Clinical Implications
Current Pharmaceutical Design Use of Trastuzumab for Breast Cancer: The Role of Age
Current Pharmaceutical Design Standardization of Procedures for the Preparation of <sup>177</sup>Lu- and <sup>90</sup>Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation
Current Radiopharmaceuticals Identification of Novel Potent Inhibitors Against Bcl-xL Anti-apoptotic Protein Using Docking Studies
Protein & Peptide Letters DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Current Molecular Medicine Novel and Emerging Drugs for Acute Myeloid Leukemia
Current Cancer Drug Targets Recent Development and Application of Magnetic Nanoparticles for Cell Labeling and Imaging
Mini-Reviews in Medicinal Chemistry